Tongluo Shenggu Jiaonang (通络生骨胶囊)通络生骨胶囊
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 浙江海正药业股份有限公司Chinese legal name: 浙江海正药业股份有限公司
主要成分Active Ingredients
- 木豆叶Mudou Ye
药物知识说明
木豆叶是一种在国家药监局注册认定的药品。标注生产企业为浙江海正药业股份有限公司。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为：浙江海正药业股份有限公司Chinese legal name: 浙江海正药业股份有限公司、浙江海正药业股份有限公司Chinese legal name: 浙江海正药业股份有限公司、浙江海正药业股份有限公司Chinese legal name: 浙江海正药业股份有限公司。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 通络生骨胶囊) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 浙江海正药业股份有限公司.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 浙江海正药业股份有限公司Chinese legal name: 浙江海正药业股份有限公司, 浙江海正药业股份有限公司Chinese legal name: 浙江海正药业股份有限公司, 浙江海正药业股份有限公司Chinese legal name: 浙江海正药业股份有限公司.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 通络生骨胶囊Recorded Chinese name: 通络生骨胶囊
- 剂型Dosage form: 胶囊剂Capsules
- 规格Specification: 0.5g*36粒0.5 g × 36 capsules
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 浙江海正药业股份有限公司Chinese legal name: 浙江海正药业股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字Z20040001
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字Z20040001
Manufacturer
Chinese legal name: 浙江海正药业股份有限公司 (domestically manufactured)
Traditional functions
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
0.5 g × 36 capsules
中文说明书原文Original Chinese source label
批准文号
国药准字Z20040001
生产企业
浙江海正药业股份有限公司(国产)
功能主治
本品具有活血健骨，化瘀止痛功能，用于股头缺血性坏死，症状髋部活动受限，疼痛，跛行，肌肉萎缩，腰膝酸软，乏力倦怠，舌质偏红或有淤斑，脉弦等症状。
用法用量
口服，一次4粒，一日3次。
不良反应
1.个别病人服用后出现ALT升高，与服用本品的关系尚未明确。
2.个别病人服用后可能出现轻微的胃部不适、腹泻、潮热、皮肤瘙痒。
禁忌
尚不明确。
注意事项
1.若疼痛持续加剧，请咨询专科医生。
2.肝肾功能不全者慎用。
3.小儿遵医嘱用药。
4.服用本品期间，个别患者可能出现短暂的髋关节疼痛加剧，这是死骨吸收的正常反应，此时应注意减轻负重。
贮藏
密封，置阴凉（不超过20℃）干燥处保存。
规格
0.5g*36粒
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.